|
Updated section(s) d4, g3, g6, h2, h3, h4 and h6: (h3) the sensor remains implanted and was not returned for evaluation.A review of the device history record (dhr) for the associated lot confirmed that all manufacturing operations and inspections were completed per specifications, acceptance criteria were met, and no relevant nonconformances were identified at the time of manufacture.Approximately 11150 days post-implantation of the mycordella sensor, the patient underwent a scheduled 3-year right heart catheterization (rhc) recalibration.During this procedure, the offset measured fell outside the acceptable fluid-filled reference error range, indicating that the sensor was providing inaccurate pulmonary artery pressure readings.The observed drift, although rare, may be attributed to factors such as physical damage or an in vivo drift/settling profile that deviates from the correction parameters derived during manufacturing.Recalibration was successfully performed, confirming the drift was finite, the sensor was undamaged, and the corrective action restored the system to its intended accuracy.Based on available data, the most probable cause of the drift was an in vivo settling profile inconsistent with manufacturing-derived expectations.No further complications were reported following recalibration, and the system continues to operate within specified performance parameters.
|
|
Updatedsection(s) b1, b2, b5, b6, g3, g6.H1, h2 and h6.(b5) additional information received indicates that a right heart catheterization (rhc) was performed to confirm the accuracy of the pressure sensor against a reference pressure.The sensor was found to be outside the range of accuracy; therefore, a calibration during rhc via swan-ganz confirmed that a sensor adjustment of 14.0mmhg was required.Additional information will be submitted via follow-up report within 30 days of receipt.
|